Myomo Q2 revenue $11.7M (+21% YoY); raises FY guidance to $45-47M

MYOMO, INC.

Revenue $11.7M, up 21% YoY; gross margin 72.1% vs 62.7% last year.
Net loss $4.0M ($0.09/share) includes $1.2M non-cash derivative mark; operating loss improved to $2.3M from $4.6M.
Adjusted EBITDA loss improved 79% to $0.8M from $4.0M.
Record 255 orders in Q2 (+23% YoY); 53% of revenue from recurring patient sources (up from 26%).
Raises FY 2026 revenue guidance to $45-47M; Q3 guidance $11.5-12.0M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.